Latest / Decera Clinical Education Oncology Podcast
PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provides perspectives on the clinical implications of these data for patients with chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL), including:
CLL17: randomized phase III trial of continuous ibrutinib vs fixed-duration venetoclax plus obinutuzumab or venetoclax plus ibrutinib for untreatedCLL
BRUIN CLL-313: randomized phase III trial of pirtobrutinib vs BR for previously untreated patients with CLL…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.